LIOTON

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Hong Kong SAR China, Lithuania, Malta, Poland, Romania.

Active ingredients

The drug LIOTON contains one active pharmaceutical ingredient (API):

1	Heparin UNII ZZ45AB24CA - HEPARIN SODIUM
	Heparin is an anticoagulant and acts by inhibiting thrombin and by potentiating the naturally occurring inhibitors of activated Factor X (Xa).
	Read more about Heparin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LIOTON Gel	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C05BA03	Heparin	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use
Discover more medicines within C05BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1014578, 1071784, 1269042
HK	Department of Health Drug Office	25113
HR	Agencija za lijekove i medicinske proizvode	HR-H-931918675
LT	Valstybinė vaistų kontrolės tarnyba	1006530, 1006531, 1024093
MT	Medicines Authority	MA205/00201
PL	Rejestru Produktów Leczniczych	100080800
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W03453001, W03453002, W03453003, W03453004